November 15, 2024- Cardinal Health’s Global Medical Products and Distribution business recently celebrated the grand opening of its new Scientific Services Chemistry Center, a state-of-the-art testing and FDA-regulated laboratory located within its Mansfield, Massachusetts, office. The Chemistry Center includes nearly 26,000 square feet of lab space dedicated to innovation and … [Read more...]
Sg2 data highlights urgency for increased cardiovascular intervention resources in US hospitals
November 15, 2024- Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and the related challenge of timely patient access to lifesaving interventions such as transcatheter aortic valve replacement (TAVR) procedures. The paper, “The Rising Tide of Cardiovascular Disease: A Looming Crisis for Cardiovascular … [Read more...]
GHX opens early registration for its 25th Annual Summit
November 14, 2024- Global Healthcare Exchange (GHX) announced that early registration has opened for its annual GHX Summit. In 2025, GHX will proudly celebrate 25 years of innovation and excellence in healthcare supply chain management, marking both the company’s milestone anniversary and the quarter-century legacy of its annual customer and industry event. Next year’s GHX … [Read more...]
Vizient assesses CABG, factors affecting orthopedic procedures in ambulatory settings
November 14, 2024- Vizient, Inc. assesses coronary artery bypass graft (CABG) techniques and costs as well as factors affecting orthopedic procedures in non-acute settings in the latest Medical Device Tech Watch. The publication also reviews advancements in internal leg lengthening for children with congenital femoral deficiency. Featured articles include: Coronary … [Read more...]
Premier data: Navigating patient access challenges to enhance care and grow revenue
November 14, 2024- Patient access is a key driver of patient acquisition, satisfaction and retention – all of which deeply influence care quality and provider revenue. Today, patients seeking convenient and timely care options gravitate toward providers who offer optimal access, whether that means shorter wait times, flexible scheduling or easy connections to specialty … [Read more...]
Janelle Begole joins Healthcare Links team
November 14, 2024- Janelle Begole is the newest member of the Healthcare Links team, bringing over 40 years of experience in Corporate and Key Account Management. She is a results-driven professional who has built and led national teams to secure and expand relationships with Group Purchasing Organizations (GPO), Integrated Delivery Networks (IDN), and Government Contracting … [Read more...]
Gartner announces ranking of the Gartner Healthcare Supply Chain Top 25 for 2024
November 14, 2024- Gartner, Inc. has released its 16th annual Gartner Healthcare Supply Chain Top 25 ranking, which recognizes U.S. health systems that demonstrate leadership in supply chain. AdventHealth claims the top spot for the first time, jumping two spots from 2023. Stanford Health Care, Bon Secours Mercy Health, Corewell Health and Banner Health round out the … [Read more...]
Ontada collaborates with Datavant to enable faster access to market-leading oncology insights
November 13, 2024- Ontada®, a McKesson business, has announced a strategic collaboration with Datavant, a health data platform, to include Ontada’s data in their health ecosystem. This collaboration aims to help life science companies quickly access Ontada’s real-world data, accelerating the discovery of critical insights that drive oncology innovation and improve the lives of … [Read more...]
Claire Zangerle named Chief Nurse Executive of the AHA and Chief Executive Officer of AONL
November 13, 2024- The American Hospital Association (AHA) has named Claire M. Zangerle, DNP, R.N., as senior vice president and chief nurse executive of AHA and chief executive officer of its American Organization for Nursing Leadership (AONL). In these roles, Zangerle will provide critical clinical expertise to the AHA, supporting key quality and workforce initiatives and … [Read more...]
FDA proposes ending use of oral phenylephrine as OTC monograph nasal decongestant active ingredient
November 13, 2024- The U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the temporary relief of nasal congestion after an agency review of the available data determined that oral phenylephrine is not effective for this use. Currently, oral … [Read more...]